Form 8-K - Current report:
SEC Accession No. 0001193125-14-021166
Filing Date
2014-01-27
Accepted
2014-01-27 08:00:52
Documents
3
Period of Report
2014-01-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d663089d8k.htm 8-K 15047
2 EX-99.1 d663089dex991.htm EX-99.1 13609
3 GRAPHIC g663089g48c01.jpg GRAPHIC 23682
  Complete submission text file 0001193125-14-021166.txt   62622
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 14547425
SIC: 2834 Pharmaceutical Preparations